| Group | Location (as stated) | Key markers listed |
|---|---|---|
| Kupffer cells | Sinusoidal lumen, zonated portally | Tim4, CRIg/VSIG4, Clec2/Clec4f; CD5L, MARCO, CD163, FOLR2 (plus general markers noted) |
| Liver capsule macrophages (LCMs) | Under mesothelium on liver surface | CX3CR1, low CD11c (lack Kupffer markers CRIg/Tim4) |
| Central vein macrophages | Near central vein | CX3CR1 (expression similarities to LCMs noted) |
| Bile duct macrophages / LAM-like near bile ducts | Near epithelial bile ducts | Gpnmb1, Spp1, Trem2, CD9 |
The review frames human liver disease relevance through (i) loss of homeostatic Kupffer-cell states, (ii) expansion of monocyte-derived and LAM-associated macrophage programs in fibrosis/cirrhosis contexts, and (iii) the impact of disrupted niches.
Skeptical caution: the review itself notes unresolved questions about how to map mouse lineage/marker logic onto human macrophage identities, especially given technological differences and marker/protein discordance.
Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.